Nevertheless, in a small proportion (10–15%) of LBC, the defect lies in accessory molecules of the cadherin–catenin complex, which include α-catenin, β-catenin and p120 catenin [44]. This evidence concerns the gene CDH17 and CDH1-related diffuse gastric and lobular breast cancer syndrome.